Arkolith/Funds/H&F Corporate Investors X, Ltd.

H&F Corporate Investors X, Ltd.

CIK 1901930
Holdings as of Mar 31, 2026·disclosed May 11, 2026·~41-day 13F lag·13F-HR
Inactive

H&F Corporate Investors X, Ltd. holds a concentrated book of 1 stock worth $3.8B as of Q1 2026 (disclosed May 11, 2026, a ~45-day 13F lag). This quarter they trimmed MEDLINE INC-CL A. Their largest long position is MEDLINE INC-CL A at 100% of the equity book.

Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp
Build

Ask your agent what H&F Corporate Investors X, Ltd. owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Get a key Compare plans13F data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1901930/holdings"
Ask your agent
Use Arkolith to show H&F Corporate Investors X, Ltd.'s latest
holdings, largest changes, and filing provenance.
Opened
0
new positions
Added to
0
existing
Trimmed
1
reduced
Sold out
0
exited

Concentration

Top-heavy: concentrated book

Top 5 holdings
100%
Top 10 holdings
100%
Top 20 holdings
100%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Direct sector allocation

100% mapped to company sectors

Health Care
100%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices, no cost basis

Bought

No buys this quarter.

Trimmed / exited

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

1 positions
#SecurityValueShares% PortLast moveHistory
1Medline Inc
COM CL A
$3.8B86.47M
100.0%
▼−13%
Reduced · −13.0M sh
Showing all 1 positions

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q1 2026Mar 31, 2026May 11, 20261$3.8B13F-HR
Q4 2025Dec 31, 2025Feb 13, 20261$4.2B13F-HR
Q3 2025Sep 30, 2025Nov 12, 20251$013F-HR
Q2 2025Jun 30, 2025Aug 12, 20251$013F-HR
Q1 2025Mar 31, 2025May 13, 20251$013F-HR
Q4 2024Dec 31, 2024Feb 12, 20251$013F-HR
Q3 2024Sep 30, 2024Nov 13, 20241$013F-HR
Q2 2024Jun 30, 2024Aug 14, 20241$013F-HR
Q1 2024Mar 31, 2024May 13, 20241$013F-HR
Q4 2023Dec 31, 2023Feb 13, 20241$2.0B13F-HR
Q3 2023Sep 30, 2023Nov 13, 20231$1.9B13F-HR
Q2 2023Jun 30, 2023Aug 11, 20231$1.4B13F-HR
Q1 2023Mar 31, 2023May 4, 20231$1.2B13F-HR
Q4 2022Dec 31, 2022Jan 30, 20231$1.1B13F-HR
Q3 2022Sep 30, 2022Nov 14, 20221$962.5M13F-HR
Q2 2022Jun 30, 2022Aug 9, 20221$1.1B13F-HR
Q1 2022Mar 31, 2022May 16, 20221$1.8B13F-HR

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.